Janus Shareholders Approve Merger with Henderson Group
Apr 25, 2017 20:31 pm UTC| Business
DENVER, April 25, 2017 -- Janus Capital Group Inc. (“Janus”) (NYSE:JNS) today announced that Janus shareholders approved the agreement and plan of merger with Henderson Group plc (“Henderson”) (LSE:HGG) (ASX:HGG) dated...
Janus Shareholders Approve Merger with Henderson Group
Apr 25, 2017 20:31 pm UTC| Business
DENVER, April 25, 2017 -- Janus Capital Group Inc. (“Janus”) (NYSE:JNS) today announced that Janus shareholders approved the agreement and plan of merger with Henderson Group plc (“Henderson”) (LSE:HGG) (ASX:HGG) dated...
GCP Applied Technologies to Announce First Quarter 2017 Results on May 9, 2017
Apr 25, 2017 20:31 pm UTC| Business
CAMBRIDGE, Mass., April 25, 2017 -- GCP Applied Technologies Inc. (NYSE:GCP), a leading global provider of products and technology solutions for the specialty construction chemicals, specialty building materials, and...
GCP Applied Technologies to Announce First Quarter 2017 Results on May 9, 2017
Apr 25, 2017 20:31 pm UTC| Business
CAMBRIDGE, Mass., April 25, 2017 -- GCP Applied Technologies Inc. (NYSE:GCP), a leading global provider of products and technology solutions for the specialty construction chemicals, specialty building materials, and...
Churchill Downs Incorporated Announces New $250 Million Share Repurchase Program
Apr 25, 2017 20:30 pm UTC| Business
LOUISVILLE, Ky., April 25, 2017 -- At its regular scheduled meeting held April 25, 2017, the Board of Directors of Churchill Downs Incorporated (NASDAQ:CHDN) (CDI) approved a new common stock repurchase program of up to...
Amarin to Report First Quarter 2017 Results and Host Conference Call on May 3, 2017
Apr 25, 2017 20:30 pm UTC| Business
BEDMINSTER, N.J., and DUBLIN, Ireland, April 25, 2017 -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular...
Apr 25, 2017 20:30 pm UTC| Business
TORONTO, April 25, 2017 -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), an emerging medical device company focused on prostate care, will announce its first quarter 2017 financial...
India–EU FTA Nears Finish Line Ahead of New Delhi Summit